STZ eyetrial
In research, STZ eyetrial stands highest in Medicine (#6,682 of 10,443 worldwide) and Health Sciences (#8,098 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Ophthalmology and Molecular Biology — Ophthalmology is 52.5× its share of world research.
- World rank, 2022–2025
- #13,051 of 28,054 · #10,774 all time
- Rank in Germany
- #505 of 1,178
- Research works
- 1.6k ▼ 16% vs 2013–17
- Citations
- 42k 26.0 per fractional work
- Top-10% rate
- 19.8% record average 16.5%
- Open access
- 32% world 28%
What is STZ eyetrial known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #6,682 of 10,443 | 21.0% | 99 | #6106 | |
| Health SciencesDomain | #8,098 of 11,982 | 20.9% | 101 | #7340 |
Each strip is that field’s whole ranked pool, with the notch where STZ eyetrial sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does STZ eyetrial specialise in?
Where its research is concentrated relative to its size: Ophthalmology takes 52.5× the share of its output that it takes of world research.
- OphthalmologySubfield · 23.8 works52×
- Molecular BiologySubfield · 23.9 works4.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 5.4×. Every wedge is a field page.
- Neuroscience 5.4×
- Biochemistry, Genetics and Molecular Biology 3.6×
- Medicine 3.0×
- Immunology and Microbiology 1.8×
- Psychology 0.7×
- Chemistry 0.5×
- Arts and Humanities 0.5×
- Dentistry 0.4×
- Nursing 0.4×
- Health Professions 0.3×
- Chemical Engineering 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Physics and Astronomy 0.2×
- Computer Science 0.2×
- Energy 0.2×
- Mathematics 0.2×
- Materials Science 0.2×
- Earth and Planetary Sciences 0.2×
- Economics, Econometrics and Finance 0.1×
- Environmental Science 0.1×
- Engineering 0.1×
- Social Sciences 0.1×
- Decision Sciences 0.0×
Who are the top researchers at STZ eyetrial?
Ranked on the composite score, Lindsay T. Sharpe, Ulrich Schraermeyer and Susanne Beck lead among researchers whose main affiliation is STZ eyetrial.
- 1 Lindsay T. Sharpe Germany · #81,738 worldwide 283 citations · 28 works
- 2 Ulrich Schraermeyer Germany · #216,263 worldwide 176 citations · 23 works
- 3 Susanne Beck Germany · #359,159 worldwide 52 citations · 28 works
- 4 Mathias W. Seeliger Germany · #362,996 worldwide 93 citations · 33 works
- 5 Frank Schaeffel Germany · #421,996 worldwide 303 citations · 171 works
- 6 Florian Gekeler Germany · #434,297 worldwide 90 citations · 33 works
- 7 Susanne Trauzettel‐Klosinski Germany · #454,453 worldwide 69 citations · 21 works
- 8 Barbara Wilhelm Germany · #477,447 worldwide 142 citations · 43 works
- 9 Helmut Wilhelm Germany · #566,874 worldwide 91 citations · 31 works
- 10 Eberhart Zrenner Germany · #618,790 worldwide 279 citations · 135 works
Which keywords describe research at STZ eyetrial?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Macular Degeneration, Gene Therapy, Vascular Endothelial Growth Factor, Retinal Stem Cells, Retinitis Pigmentosa, Diabetic Retinopathy, Oxidative Stress and Inflammation.
- Neural Stimulation
- Electrode Arrays
- Electrical Stimulation
- Prognostic Factors
- Genetic Mutations
- Vitreoretinal Surgery
- OCT Imaging
- Treatment
- Visual Field Progression
- Global Prevalence
- Retinal Ganglion Cells
- Optic Nerve
- Neurodegeneration
- Intraocular Pressure
- Choroidal Thickness
- Intravitreal Injection
- Retinitis Pigmentosa
- Vascular Endothelial Growth Factor
- Inflammation
- Epidemiology
- Macular Degeneration
- Gene Therapy
- Oxidative Stress
- Retinal Stem Cells
- Diabetic Retinopathy
- Myopia
- Retinal Pigment Epithelium
- Glaucoma
- Optical Coherence Tomography
- Risk Factors
- Immunotherapy
- Ocular Hypertension
- Refractive Error
- Visual Impairment
- Macular Hole
- Corneal Biomechanics
- Keratoconus
- Innate Immunity
- Neural Processing
- Lymphoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Macular Degeneration26▲ 125×3 topics
- Epidemiology18▲ 2.7×54 topics
- Gene Therapy16▲ 48×6 topics
- Inflammation16▲ 4.4×28 topics
- Oxidative Stress15▲ 5.3×24 topics
- Vascular Endothelial Growth Factor14▲ 95×3 topics
- Retinal Stem Cells13▲ 351×1 topic
- Retinitis Pigmentosa13▲ 351×1 topic
- Diabetic Retinopathy13▲ 75×2 topics
- Intravitreal Injection12▲ 101×2 topics
- Myopia11▲ 112×2 topics
- Choroidal Thickness11▲ 124×1 topic
- Retinal Pigment Epithelium11▲ 124×1 topic
- Intraocular Pressure10▲ 73×2 topics
- Glaucoma9▲ 35×3 topics
- Neurodegeneration8▲ 17×7 topics
- Optical Coherence Tomography8▲ 48×3 topics
- Optic Nerve8▲ 47×2 topics
- Risk Factors7▲ 3.9×11 topics
- Retinal Ganglion Cells7▲ 39×2 topics
- Immunotherapy7▲ 5.5×14 topics
- Global Prevalence6▲ 42×2 topics
- Ocular Hypertension6▲ 73×1 topic
- Visual Field Progression6▲ 73×1 topic
- Refractive Error6▲ 100×1 topic
- Treatment6▲ 3.0×24 topics
- Visual Impairment6▲ 79×1 topic
- OCT Imaging5▲ 109×2 topics
- Macular Hole5▲ 133×1 topic
- Vitreoretinal Surgery5▲ 133×1 topic
- Corneal Biomechanics4▲ 73×1 topic
- Genetic Mutations4▲ 5.6×16 topics
- Keratoconus4▲ 73×1 topic
- Prognostic Factors4▲ 5.3×12 topics
- Innate Immunity3▲ 6.3×7 topics
- Electrical Stimulation3▲ 32×2 topics
- Neural Processing3▲ 28×2 topics
- Electrode Arrays3▲ 37×1 topic
- Lymphoma3▲ 11×3 topics
- Neural Stimulation3▲ 37×1 topic
Which research topics does STZ eyetrial publish most on?
By volume in 2022–2025: Retinal Development and Disorders, Retinal Diseases and Treatments, Glaucoma and retinal disorders and Ophthalmology and Visual Impairment Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Retinal Development and Disorders Molecular Biology 13 works
- 2 Retinal Diseases and Treatments Ophthalmology 11 works
- 3 Glaucoma and retinal disorders Ophthalmology 6 works
- 4 Ophthalmology and Visual Impairment Studies Epidemiology 6 works
- 5 Retinal and Macular Surgery Radiology, Nuclear Medicine and Imaging 5 works
- 6 Corneal surgery and disorders Radiology, Nuclear Medicine and Imaging 4 works
- 7 Neuroscience and Neural Engineering Cellular and Molecular Neuroscience 3 works
- 8 Visual perception and processing mechanisms Cognitive Neuroscience 3 works
- 9 Retinopathy of Prematurity Studies Radiology, Nuclear Medicine and Imaging 2 works
- 10 CAR-T cell therapy research Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has STZ eyetrial's research output changed?
Output in 2018–2022 was 16% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tübingen
- University of Tübingen
- Universitäts Frauenklinik
- Universitätsklinikum Tübingen
- Max Planck Institute for Biological Cybernetics
- University Children's Hospital Tübingen
- Bernstein Center for Computational Neuroscience Tübingen
- Max Planck Institute for Biology
- Max Planck Institute for Developmental Biology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.